Seattle Genetics is a $4 billion biotechnology company focused on developing and commercializing innovative antibody-based therapies for the treatment of cancer. They are the industry leaders in antibody-drug conjugates , a technology designed to harness the targeting ability of monoclonal antibodies to deliver cell-killing agents directly to cancer cells.
http://ift.tt/1wsZ4FR
http://ift.tt/1wsZ4FR
No comments:
Post a Comment